Related news from |
Mon, 22 Apr 2024 10:49:04 +0000 |
Shareholders in Teleflex (NYSE:TFX) are in the red if they invested three years ago
Investing in stocks inevitably means buying into some companies that perform poorly. But the last three years have been...
|
Thu, 18 Apr 2024 10:30:00 +0000 |
Teleflex Announces First Quarter 2024 Earnings Conference Call Information
WAYNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, May 2, 2024. To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company’s website, teleflex.com. An audio replay of the call will be availab
|
Mon, 08 Apr 2024 12:18:00 +0000 |
Teleflex (TFX) Debuts the New Unified UroLift 2 System With ATC
Teleflex's (TFX) new UroLift 2 System with the ATC platform is designed to treat all prostate types.
|
Thu, 04 Apr 2024 09:28:00 +0000 |
Teleflex catheterization kit recall linked to 10 injuries, 1 death
Nearly 335,000 devices were recalled due to safety issues, which may cause damage to blood vessel walls, artery blockage or death.
|
Tue, 02 Apr 2024 10:30:00 +0000 |
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced Tissue Control (ATC) feature on its unified UroLift™ 2 System platform designed for the treatment of benign prostatic hyperplasia (BPH) symptoms in men with all prostate types up to 100g. The UroLift™ 2 System with Advanced Tissue Control (UroLift™ 2 ATC) has received FDA clearance, marking a significa
|
Thu, 28 Mar 2024 10:30:00 +0000 |
Teleflex’s Climate Targets Validated by the Science Based Targets Initiative
Teleflex commits to reach net-zero greenhouse gas emissions across its value chain by 2050.WAYNE, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced its near- and long-term climate change targets have been validated by the Science Based Targets initiative (SBTi). The announcement comes ahead of the company’s release of its 2023 Global Impact Report, which will be published in May 2024. Teleflex has respond
|
Sun, 24 Mar 2024 14:38:04 +0000 |
Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 60% Above Its Share Price
Key Insights The projected fair value for Teleflex is US$354 based on 2 Stage Free Cash Flow to Equity Teleflex's...
|
Mon, 11 Mar 2024 13:18:00 +0000 |
Here's Why You Should Retain Teleflex (TFX) Stock for Now
Investors are optimistic about Teleflex (TFX) on robust growth in the Vascular business and strong Urolift prospects.
|
Sat, 24 Feb 2024 05:08:31 +0000 |
Decoding Teleflex Inc (TFX): A Strategic SWOT Insight
Unveiling the Strengths and Challenges: A Deep Dive into Teleflex Inc (TFX) SWOT Analysis
|
Fri, 23 Feb 2024 17:13:06 +0000 |
Teleflex Incorporated (NYSE:TFX) Q4 2023 Earnings Call Transcript
Teleflex Incorporated (NYSE:TFX) Q4 2023 Earnings Call Transcript February 22, 2024 Teleflex Incorporated beats earnings expectations. Reported EPS is $3.38, expectations were $3.26. Teleflex Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome […]
|
Fri, 23 Feb 2024 13:40:00 +0000 |
Teleflex (TFX) Q4 Earnings Top Estimates, Operating Margin Falls
Teleflex (TFX) surpasses earnings and revenue estimates in the fourth quarter of 2023.
|
Fri, 23 Feb 2024 03:16:01 +0000 |
Q4 2023 Teleflex Inc Earnings Call
Q4 2023 Teleflex Inc Earnings Call
|
Thu, 22 Feb 2024 14:30:16 +0000 |
Compared to Estimates, Teleflex (TFX) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Teleflex (TFX) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
|
Thu, 22 Feb 2024 12:45:03 +0000 |
Teleflex (TFX) Q4 Earnings and Revenues Surpass Estimates
Teleflex (TFX) delivered earnings and revenue surprises of 3.68% and 0.71%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
|
Thu, 22 Feb 2024 11:45:00 +0000 |
Teleflex Announces Quarterly Dividend
WAYNE, Pa., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 15, 2024, to shareholders of record at the close of business on March 1, 2024. Additional information about Teleflex can be obtained from the company’s website at teleflex.com. About Teleflex Incorporated Teleflex is a global provider of medical technolog
|
Thu, 22 Feb 2024 11:30:00 +0000 |
Teleflex Reports Fourth Quarter and Full Year 2023 Financial Results
WAYNE, Pa., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter ended December 31, 2023. Fourth quarter financial summary Revenues of $773.9 million, reflective of five fewer shipping days year-over-year, up 2.1% compared to the prior year period; up 0.7% on a constant currency basis GAAP diluted EPS from continuing operations of $0.66, compared to $1.65 in the prior year period Adjusted diluted EPS from con
|
Wed, 21 Feb 2024 14:40:11 +0000 |
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
|
Tue, 20 Feb 2024 11:30:00 +0000 |
Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference
WAYNE, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 45th Annual Raymond James Institutional Investors Conference at the JW Marriott Orlando Grande Lakes, Orlando, FL, on Tuesday, March 5, 2024, at 1:40 p.m. (ET). A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor section of the Teleflex website at teleflex.com. Abou
|
Mon, 19 Feb 2024 15:00:14 +0000 |
Si-Bone (SIBN) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Si-Bone (SIBN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
|
Mon, 19 Feb 2024 14:15:55 +0000 |
Countdown to Teleflex (TFX) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Beyond analysts' top -and-bottom-line estimates for Teleflex (TFX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
|